# Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

> **NCT05009199** · PHASE1 · COMPLETED · sponsor: **Invicro** · enrollment: 3 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** [18F]MNI-444

## Key facts

- **NCT ID:** NCT05009199
- **Lead sponsor:** Invicro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-24
- **Primary completion:** 2022-05-12
- **Final completion:** 2022-05-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05009199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05009199, "Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05009199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*